Immunome Inc. Quarterly Operating Income (Loss) in USD from Q3 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Immunome Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2024.
Immunome Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$50.5M, a 990% decline year-over-year.
Immunome Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$317M, a 1301% decline year-over-year.
Immunome Inc. annual Operating Income (Loss) for 2023 was -$110M, a 197% decline from 2022.
Immunome Inc. annual Operating Income (Loss) for 2022 was -$36.9M, a 46.4% decline from 2021.
Immunome Inc. annual Operating Income (Loss) for 2021 was -$25.2M, a 106% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$317M	-$50.5M	-$45.9M	-990%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-13
Q2 2024	-$272M	-$40M	-$34.2M	-593%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	-$237M	-$132M	-$128M	-2859%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	-$110M	-$94.7M	-$86.9M	-1116%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-28
Q3 2023	-$22.7M	-$4.63M	+$3.9M	+45.7%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-13
Q2 2023	-$26.6M	-$5.77M	+$3.15M	+35.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-12
Q1 2023	-$29.7M	-$4.47M	+$7.18M	+61.6%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-14
Q4 2022	-$36.9M	-$7.79M	+$57K	+0.73%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-28
Q3 2022	-$37M	-$8.53M	-$811K	-10.5%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-09
Q2 2022	-$36.1M	-$8.93M	-$3.19M	-55.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	-$33M	-$11.7M	-$7.76M	-199%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-05
Q4 2021	-$25.2M	-$7.84M	-$3.77M	-92.6%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-16
Q3 2021	-$21.4M	-$7.72M	-$4.91M	-174%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$16.5M	-$5.74M	-$3.03M	-111%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-05
Q1 2021	-$13.5M	-$3.9M	-$1.24M	-46.8%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	-$12.3M	-$4.07M			Oct 1, 2020	Dec 31, 2020	10-K	2022-03-28
Q3 2020		-$2.82M	-$98K	-3.6%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020		-$2.72M			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020		-$2.66M			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-12
Q3 2019		-$2.72M			Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-16

* An asterisk sign (*) next to the value indicates that the value is likely invalid.